Cited by 98Diabetes Management and ResearchDiabetes Management and EducationDiabetes and associated disorders

Durability of Insulin Pump Use in Pediatric Patients With Type 1 Diabetes

Open access
Wood, Jamie R., Moreland, Elaine C., Volkening, Lisa K., Svoren, Britta M., Butler, Deborah A., Laffel, Lori M.B.·2006·Diabetes Care

Abstract

OBJECTIVE—To examine longitudinal outcomes, rate of and reasons for discontinuation, and predictors of insulin pump success in a cohort of youth initiating pump therapy. RESEARCH DESIGN AND METHODS—We followed a cohort of youth with type 1 diabetes (n = 161) starting the pump between 1998 and 2001 and recorded natural history of treatment. RESULTS—At pump start, patients (71% female) had a mean age of 14.1 ± 3.7 years, diabetes duration of 7.1 ± 4.0 years, daily blood glucose monitoring (BGM) frequency of 4.0 ± 1.2, a daily insulin dose of 1.0 ± 0.3 units/kg, and an HbA1c (A1C) of 8.4 ± 1.4%. After 1 year, mean daily BGM frequency was 4.5 ± 1.7, daily insulin dose was 0.8 ± 0.2 units/kg, and A1C was 8.1 ± 1.3% (all baseline versus 1-year data, P < 0.01). As of 2005, 29 patients (18%) had resumed injection therapy at a mean age of 17.0 ± 2.9 years after a mean duration of pump use of 2.1 ± 1.3 years. BGM frequency at baseline and at 1 year was significantly lower in the patients who resumed injection therapy (P < 0.02). In addition, patients who remained on the pump had lower A1C than those who resumed injection therapy at both 1 year (P = 0.04) and at the most recent clinic visit (P = 0.01). CONCLUSIONS—After an average of 3.8 years, >80% of pediatric patients maintained pump therapy with preservation of baseline A1C. Patients discontinuing the pump were less adherent and did not achieve equivalent glycemic benefit compared with continued users; these patients require ongoing support aimed at improving adherence and outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc06-1141

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insulin pump discontinuation is commonly due to IIS failure.

    “This aligns with previous findings that insulin pump discontinuation is commonly due to IIS failure.19”

    From Frequency and Detection of Insulin Infusion Site Failure in the Type 1 Diabetes Exchange Online Community (2023) · cites this paper as [19]

    The Results and Conclusions (page unavailable) identify infusion-site issues as one of the common reasons for discontinuation in this pediatric cohort; minor problems such as infusion-site issues accounted for 21% of discontinuations. The paper does not identify insulin infusion set (IIS) failure specifically as the cause, so the claim is more specific than the evidence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Problems with infusion sets are a reason for patients discontinuing insulin pump therapy.

    “and a reason for patients discontinuing insulin pump therapy. 21,37-39”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wood, J. R., Moreland, E. C., Volkening, L. K., Svoren, B. M., Butler, D. A., & Laffel, L. M. B.
Affiliations
Joslin Diabetes Center (US)
Venue
Diabetes Care
Published
2006-11-01
Volume
29
Issue
11
Pages
2355-2360
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2078077635
Cited by
98
References
20
Citations by year
2023: 4 · 2022: 4 · 2021: 4 · 2020: 3 · 2019: 4 · 2018: 8 · 2017: 1 · 2016: 10 · 2015: 4 · 2014: 11 · 2013: 3 · 2012: 11
FWCI
3.64
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • University of Alabama at Birmingham
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK063702, K12DK063696, R01 DK46887, R01DK046887)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
Keywords
insulin pump therapy, type 1 diabetes, pediatric patients, treatment discontinuation, glycemic control, HbA1c, blood glucose monitoring, insulin dose, predictors of treatment success
MeSH terms
Adolescent, Child, Diabetes Mellitus, Type 1, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Patient Compliance, Cohort Studies, Treatment Outcome, Patient Satisfaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review